Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: Evidence from a pilot study

Clinical Chemistry

Volumn 58, Issue 3, 2012, Pages 590-598

  Godler, David E ^a   Slater, Howard R ^a,b   Bui, Quang M ^b   Storey, Elsdon ^c   Ono, Michele Y ^d,e   Gehling, Freya ^a   Inaba, Yoshimi ^a   Francis, David ^a   Hopper, John L ^b   Kinsella, Glynda ^f   Amor, David J ^a,b   Hagerman, Randi J ^d,e   Loesch, Danuta Z ^f  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ALLELE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTELLIGENCE QUOTIENT; INTRON; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHYLATION; MUTATIONAL ANALYSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; COGNITION DISORDERS; CPG ISLANDS; DNA; DNA METHYLATION; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; INFANT; INTELLIGENCE TESTS; INTRONS; MIDDLE AGED; PILOT PROJECTS; YOUNG ADULT;

EID: 84857847739     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.177626     Document Type: Article

References (42)

1. Loesch DZ, Bui QM, Dissanayake C, Clifford S, Gould E, Bulhak-Paterson D, et al. Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neurosci Biobehav Rev 2007;31:315-26. (Pubitemid 46241448)
2. Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, et al. Advances in the treatment of fragile X syndrome. Pediatrics 2009;123:378-90.
3. Pietrobono R, Tabolacci E, Zalfa F, Zito I, Terracciano A, Moscato U, et al. Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum Mol Genet 2005;14:267-77.
4. Irwin SA, Galvez R, Greenough WT. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex 2000;10: 1038-44.
5. Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117:376-82. (Pubitemid 41194564)
6. Tassone F, Hagerman RJ, Chamberlain WD, Hagerman PJ. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet 2000;97:195-203. (Pubitemid 32059207)
7. Devys D, Biancalana V, Rousseau F, Boue J, Mandel JL, Oberle I. Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am J Med Genet 1992;43:208-16.
8. Kaufmann WE, Abrams MT, Chen W, Reiss AL. Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome. Am J Med Genet 1999;83:286-95. (Pubitemid 29162630)
9. Godler DE, Tassone F, Loesch DZ, Taylor AK, Gehling F, Hagerman RJ, et al. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet 2010;19:1618-32.
10. Jin P, Warren ST. Understanding the molecular basis of fragile X syndrome. Hum Mol Genet 2000;9:901-8. (Pubitemid 30216101)
11. de Vries BB, Wiegers AM, Smits AP, Mohkamsing S, Duivenvoorden HJ, Fryns JP, et al. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet 1996;58:1025-32. (Pubitemid 26115174)
12. Taylor AK, Safanda JF, Fall MZ, Quince C, Lang KA, Hull CE, et al. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA 1994;271:507-14. (Pubitemid 24050314)
13. Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, O'Connor RA, et al. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 1994; 51:298-308. (Pubitemid 24197696)
14. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991;66:817-22. (Pubitemid 121001715)
15. Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, et al. A novel FMR1 PCR method for the routine detection of low-abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 2010;56:399-408.
16. Hornstra IK, Nelson DL, Warren ST, Yang TP. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum Mol Genet 1993;2:1659-65. (Pubitemid 23358685)
17. Nygren AO, Lens SI, Carvalho R. Methylationspecific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and fullmutation alleles. J Mol Diagn 2008;10:496-501.
18. Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, Warren ST. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 2009;85:503-14.
19. ngenotype classification using a methylation specific triple PCR assay. J Med Genet 2004;41:e45.
20. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 2007;35: e119.
21. Pietrobono R, Pomponi MG, Tabolacci E, Oostra B, Chiurazzi P, Neri G. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res 2002; 30:3278-85. (Pubitemid 34846192)
22. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010;466:253-7.
23. Bromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS. Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J 2010;24:2273-80.
24. Jowaed A, Schmitt I, Kaut O, Wullner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci 2010;30:6355-9.
25. Godler DE Slater HR, Bui QM, Ono M, Gehling F, Francis D, et al. FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles. J Mol Diagn 2011;13: 528-36.
26. Loesch DZ, Huggins RM, Bui QM, Epstein JL, Taylor AK, Hagerman RJ. Effect of the deficits of fragile X mental retardation protein on cognitive status of fragile X males and females assessed by robust pedigree analysis. J Dev Behav Pediatr 2002;23:416-23. (Pubitemid 36054485)
27. Wechsler D. The Wechsler intelligence scale for children. 3rd ed. San Antonio (TX): The Psychological Corporation; 1991.
28. Tassone F, Hagerman RJ, Ikle DN, Dyer PN, Lampe M, Willemsen R, et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 1999;84:250-61. (Pubitemid 29206978)
29. Khaniani MS, Kalitsis P, Burgess T, Slater HR. An improved diagnostic PCR assay for identification of cryptic heterozygosity for CGG triplet repeat alleles in the fragile X gene (FMR1). Mol Cytogenet 2008;1:5.
30. Loesch DZ, Huggins RM, Taylor AK. Application of robust pedigree analysis in studies of complex genotype-phenotype relationships in fragile X syndrome. Am J Med Genet 2002;107:136-42. (Pubitemid 34038595)
31. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
32. The Comprehensive R Archive Network. rms: regression modeling strategies. http://CRAN.R-project. org/package=rms (Accessed December 2011).
33. The Comprehensive R Archive Network. DiagnosisMed: diagnostic test accuracy evaluation for medical professionals. http://CRAN.R-project. org/package=DiagnosisMed (Accessed December 2011).
34. R Development Core Team. R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2007. http://www.r-project.org/ (Accessed February 2009).
35. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995;57:289-300.
36. The Comprehensive R Archive Network. MMIX: model selection uncertainty and model mixing. http://CRAN.R-project.org/package=MMIX (Accessed December 2011).
37. Wechsler D. WAIS-III: administration and scoring manual: Wechsler adult intelligence scale-third edition. Orlando (FL): The Psychological Corporation; 1997.
38. Loesch DZ, Huggins RM, Bui QM, Taylor AK, Pratt C, Epstein J, Hagerman RJ. Effect of fragile X status categories and FMRP deficits on cognitive profiles estimated by robust pedigree analysis. Am J Med Genet A 2003;122A:13-23. (Pubitemid 37071417)
39. Lachiewicz AM, Dawson DV, Spiridigliozzi GA, McConkie-Rosell A. Arithmetic difficulties in females with the fragile X premutation. Am J Med Genet A 2006;140:665-72.
40. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001;57:127-30. (Pubitemid 32634862)
41. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005;20:402-12. (Pubitemid 40277608)
42. Loesch DZ, Godler DE, Evans A, Quang MB, Gehling F, Kotschet KE, et al. Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism. Genet Med 2011;13:392-9.